Asia-Pacific Point-Of-Care Testing (POCT) Market is expected to grow with the CAGR of 10.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/apac-point-care-testing-poct-market
Point-of-care testing (POCT) market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in point-of-care testing (POCT) market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd headquartered in Basel, Switzerland, which was founded in 1896 as public owner ship. The company is engaged in creating innovative medicines and diagnostics tests that help millions of people worldwide. The company have business segment such as Pharmaceuticals, Diagnostics in which Diagnostics is the focused category. The company have wide product category such as Pharmaceuticals, Solutions for Diagnostics, Products for Researchers.
The company has wide global presence across the globe such as North America, Europe, Africa, Asia and Oceania. The company also generates its revenue from various subsidiaries such as Roche Diagnostica Brasil Ltda. (Brazil), Roche Diabetes Care Brasil Ltda. (Brazil), Trophos SA (France), INSTITUT ROCHE SAS (France) and Roche Diagnostics K.K. (Japan) among others.
Siemens Healthcare Private Limited
Siemens Healthcare Private Limited is headquartered in Erlangen, Germany and it was founded in year 1896 as private ownership. The company is engaged in the manufacturing and commercializing of laboratory diagnostics, medical imaging, digital ecosystem and reading solutions across the world. The company offers wide range of product categories such as Medical Imaging, Laboratory Diagnostics, Point of Care Testing, Digital Health Solutions, Services & Consulting, Clinical Specialties, Accessories, OEM & Electronics & Healthcare IT.
The company has presence in a North America, Europe, Asia-Pacific, South America, Middle East and Africa with its various subsidiaries such as Fast Track Diagnostics Ltd. (Europe), Siemens Healthcare Medical Solutions Limited (Germany) and Siemens Healthcare Germany (Germany) among others.
BD is headquartered in New Jersey, U.S. and founded in 1897 as public ownership. The company is engaged in manufacturing and commercializing of wide range of products such as direct testing products, environmental systems, prepared media products and others. The company have business segment such as Medical, Life Sciences and Interventional. The company has product category which are Anesthesia Delivery, Biopsy, Biosciences, Biosurgery, Cervical Cancer Screening, Diabetes Care, Drug Delivery Systems, Drainage, Gastrointestinal Care, Hazardous Drug Safety, Hernia Repair and Fixation, Home Care, Infection Prevention, Infusion Therapy, Interventional Specialties, Lab Automation, Medication and Supply Management, Microbiology Solutions, Molecular Diagnostics, Patient Monitoring and Temperature Management, Prostate Health, Respiratory Care, Sharps Disposal Solutions, Software Solutions, Specimen Collection, Surgical Instruments, Syringes and Needles, Urology and Kidney Health, Vascular Access, Wound Care.
The company has wide global presence in North America, South America, Europe, Asia-Pacific, Middle East and Africa. Accuri Cytometers, Inc. (Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), B-D (Cambridge U.K.) Ltd. (U.K.) among others.
Asia-Pacific Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2027